| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Burkitt Lymphoma and Atypical Burkitt or Burkitt-like Lymphoma: Should These be Treated as Different Diseases?
|
Thomas, Deborah A.
|
|
2010
|
6 |
1 |
p. 58-66
|
artikel
|
| 2 |
Future Therapies for the Myeloproliferative Neoplasms
|
Scherber, Robyn
|
|
2010
|
6 |
1 |
p. 22-27
|
artikel
|
| 3 |
Should Patients with Low-Risk Myelodysplastic Syndrome be Treated Earlier in the Course of Their Disease?
|
Feldman, Eric J.
|
|
2010
|
6 |
1 |
p. 1-2
|
artikel
|
| 4 |
Special Issues in Myeloproliferative Neoplasms
|
Barbui, Tiziano
|
|
2010
|
6 |
1 |
p. 28-35
|
artikel
|
| 5 |
Survival Advantage in CLL with Frontline FCR Therapy
|
O’Brien, Susan
|
|
2010
|
6 |
1 |
p. 3-4
|
artikel
|
| 6 |
The Emerging Role of Histone Deacetylase Inhibitors in Treating T-cell Lymphomas
|
Horwitz, Steven M.
|
|
2010
|
6 |
1 |
p. 67-72
|
artikel
|
| 7 |
Therapeutic Modalities for Patients with Lower-Risk Myelodysplastic Syndromes: Current Options and Future Directions
|
Navada, Shyamala C.
|
|
2010
|
6 |
1 |
p. 5-12
|
artikel
|
| 8 |
The Role of Transplantation in Diffuse Large B-Cell Lymphoma: The Impact of Rituximab Plus Chemotherapy in First-line and Relapsed Settings
|
Rodrigues, Celso Arrais
|
|
2010
|
6 |
1 |
p. 47-57
|
artikel
|
| 9 |
The Search for Better Prognostic Models in Myelodysplastic Syndromes
|
Santos, Fabio P. S.
|
|
2010
|
6 |
1 |
p. 13-21
|
artikel
|
| 10 |
What is the Best Frontline Therapy for Patients with CLL and 17p Deletion?
|
Badoux, Xavier C.
|
|
2010
|
6 |
1 |
p. 36-46
|
artikel
|
Tijdschrift beschrijving